Lumretuzumab (Anti-ERBB3 / HER3)

Lumretuzumab (Anti-ERBB3 / HER3) is an immunoconjugate containing a glycoengineered, humanized monoclonal antibody directed against the human epidermal growth factor receptor HER3 (ErbB3) with potential antineoplastic activity. MW: 147.16 KD.
Supplier Selleck Chemicals
Product # A2902
Sku # A2902-1mg*5
Pricing 1mg*5, $1390.00
Feedback